Tumour markers and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were within acceptable limits for the patient’s age and comorbidities. No biochemical evidence of active tumor-related systemic inflammation was present at baseline. Here, NPPB is linked to neoplasm.